Menu Search
Equities

Premier Inc

PM8:BER

Premier Inc

Actions
  • Price (EUR)21.60
  • Today's Change0.20 / 0.93%
  • Shares traded500.00
  • 1 Year change+16.13%
  • Beta--
Data delayed at least 15 minutes, as of Nov 14 2024 07:03 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Premier, Inc. is a healthcare improvement company, uniting an alliance of over 4,350 United States hospitals and health systems and over 325,000 other providers and organizations to transform healthcare. Its segments include Supply Chain Services and Performance Services. The Supply Chain Services segment includes its group purchasing organization program, supply chain co-management, purchased services and direct sourcing activities. The Performance Services segment consists of three sub-brands: PINC AI, its technology and services platform, Contigo Health, its direct-to-employer business, and Remitra, its digital invoicing and payables automation business. It delivers a comprehensive technology-enabled platform that offers critical supply chain services, clinical, financial, operational and value-based care software as a service and clinical and enterprise analytics license, consulting services, performance improvement collaborative programs and third-party administrator services.

  • Revenue in USD (TTM)1.28bn
  • Net income in USD147.17m
  • Incorporated2013
  • Employees2.90k
  • Location
    Premier Inc13034 Ballantyne Corporate PlaceCHARLOTTE 28277United StatesUSA
  • Phone+1 (704) 357-0022
  • Fax+1 (302) 655-5049
  • Websitehttps://www.premierinc.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.